Cargando…

A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes

BACKGROUND: Recent large-scale cancer sequencing studies have discovered many novel cancer driver genes (CDGs) in human cancers. Some studies also suggest that CDG mutations contribute to cancer-associated epigenomic and transcriptomic alterations across many cancer types. Here we aim to improve our...

Descripción completa

Detalles Bibliográficos
Autores principales: Youn, Ahrim, Kim, Kyung In, Rabadan, Raul, Tycko, Benjamin, Shen, Yufeng, Wang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218985/
https://www.ncbi.nlm.nih.gov/pubmed/30400878
http://dx.doi.org/10.1186/s12920-018-0425-z
_version_ 1783368558527381504
author Youn, Ahrim
Kim, Kyung In
Rabadan, Raul
Tycko, Benjamin
Shen, Yufeng
Wang, Shuang
author_facet Youn, Ahrim
Kim, Kyung In
Rabadan, Raul
Tycko, Benjamin
Shen, Yufeng
Wang, Shuang
author_sort Youn, Ahrim
collection PubMed
description BACKGROUND: Recent large-scale cancer sequencing studies have discovered many novel cancer driver genes (CDGs) in human cancers. Some studies also suggest that CDG mutations contribute to cancer-associated epigenomic and transcriptomic alterations across many cancer types. Here we aim to improve our understanding of the connections between CDG mutations and altered cancer cell epigenomes and transcriptomes on pan-cancer level and how these connections contribute to the known association between epigenome and transcriptome. METHOD: Using multi-omics data including somatic mutation, DNA methylation, and gene expression data of 20 cancer types from The Cancer Genome Atlas (TCGA) project, we conducted a pan-cancer analysis to identify CDGs, when mutated, have strong associations with genome-wide methylation or expression changes across cancer types, which we refer as methylation driver genes (MDGs) or expression driver genes (EDGs), respectively. RESULTS: We identified 32 MDGs, among which, eight are known chromatin modification or remodeling genes. Many of the remaining 24 MDGs are connected to chromatin regulators through either regulating their transcription or physically interacting with them as potential co-factors. We identified 29 EDGs, 26 of which are also MDGs. Further investigation on target genes’ promoters methylation and expression alteration patterns of these 26 overlapping driver genes shows that hyper-methylation of target genes’ promoters are significantly associated with down-regulation of the same target genes and hypo-methylation of target genes’ promoters are significantly associated with up-regulation of the same target genes. CONCLUSION: This finding suggests a pivotal role for genetically driven changes in chromatin remodeling in shaping DNA methylation and gene expression patterns during tumor development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12920-018-0425-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6218985
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62189852018-11-08 A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes Youn, Ahrim Kim, Kyung In Rabadan, Raul Tycko, Benjamin Shen, Yufeng Wang, Shuang BMC Med Genomics Research Article BACKGROUND: Recent large-scale cancer sequencing studies have discovered many novel cancer driver genes (CDGs) in human cancers. Some studies also suggest that CDG mutations contribute to cancer-associated epigenomic and transcriptomic alterations across many cancer types. Here we aim to improve our understanding of the connections between CDG mutations and altered cancer cell epigenomes and transcriptomes on pan-cancer level and how these connections contribute to the known association between epigenome and transcriptome. METHOD: Using multi-omics data including somatic mutation, DNA methylation, and gene expression data of 20 cancer types from The Cancer Genome Atlas (TCGA) project, we conducted a pan-cancer analysis to identify CDGs, when mutated, have strong associations with genome-wide methylation or expression changes across cancer types, which we refer as methylation driver genes (MDGs) or expression driver genes (EDGs), respectively. RESULTS: We identified 32 MDGs, among which, eight are known chromatin modification or remodeling genes. Many of the remaining 24 MDGs are connected to chromatin regulators through either regulating their transcription or physically interacting with them as potential co-factors. We identified 29 EDGs, 26 of which are also MDGs. Further investigation on target genes’ promoters methylation and expression alteration patterns of these 26 overlapping driver genes shows that hyper-methylation of target genes’ promoters are significantly associated with down-regulation of the same target genes and hypo-methylation of target genes’ promoters are significantly associated with up-regulation of the same target genes. CONCLUSION: This finding suggests a pivotal role for genetically driven changes in chromatin remodeling in shaping DNA methylation and gene expression patterns during tumor development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12920-018-0425-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-06 /pmc/articles/PMC6218985/ /pubmed/30400878 http://dx.doi.org/10.1186/s12920-018-0425-z Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Youn, Ahrim
Kim, Kyung In
Rabadan, Raul
Tycko, Benjamin
Shen, Yufeng
Wang, Shuang
A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title_full A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title_fullStr A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title_full_unstemmed A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title_short A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
title_sort pan-cancer analysis of driver gene mutations, dna methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218985/
https://www.ncbi.nlm.nih.gov/pubmed/30400878
http://dx.doi.org/10.1186/s12920-018-0425-z
work_keys_str_mv AT younahrim apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT kimkyungin apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT rabadanraul apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT tyckobenjamin apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT shenyufeng apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT wangshuang apancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT younahrim pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT kimkyungin pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT rabadanraul pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT tyckobenjamin pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT shenyufeng pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes
AT wangshuang pancanceranalysisofdrivergenemutationsdnamethylationandgeneexpressionsrevealsthatchromatinremodelingisamajormechanisminducingglobalchangesincancerepigenomes